Cantor Fitzgerald, L. P. »

Acelrx Pharmaceuticals shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2023-12-31 $300M 712k 421.32
2023-09-30 $413k 712k 0.58

More positions owned by Cantor Fitzgerald, L. P.

Acelrx Pharmaceuticals Com New (TLPH)
Ramaco Res Com Cl A (METC)
Gcm Grosvenor Com Cl A (GCMG)
Senseonics Hldgs (SENS)
Rumble Com Cl A (RUM)
22nd Centy Group Com New (XXII)
Proshares Tr Ultrapro Qqq (TQQQ)
Xbp Europe Holdings (XBP)
Wework Cl A New (WEWKQ)
Moneyhero Ord Shs (MNY)
Meta Platforms Cl A (META)
Satellogic Class A Ord Shs (SATL)
GSK Sponsored Adr (GSK)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Acelrx Pharmaceuticals

Nantahala Capital Management
Rosalind Advisors
Cantor Fitzgerald, L. P.
Tang Capital Management
Vanguard Group
Values First Advisors
Virtu Financial
Citadel Advisors
Turtle Creek Wealth Advisors
Millennium Management
Jane Street
UBS Group
Advisor Group Holdings
Wells Fargo & Company
Advisory Services Network

View all funds holding Acelrx Pharmaceuticals